Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8603022rdf:typepubmed:Citationlld:pubmed
pubmed-article:8603022lifeskim:mentionsumls-concept:C0687675lld:lifeskim
pubmed-article:8603022lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:8603022lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:8603022lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8603022pubmed:issue2lld:pubmed
pubmed-article:8603022pubmed:dateCreated1996-5-15lld:pubmed
pubmed-article:8603022pubmed:abstractTextWe have investigated whether activated protein C resistance (APCR) is associated with second-trimester miscarriage. The prevalence of APCR was significantly higher amongst women with a history of second-trimester miscarriage (10/50; 20%) compared with either women with a history of first-trimester miscarriages only (4/70; 5.7%) or a control group of parous women with no previous history of pregnancy losses (3/70; 4.3%) (P < 0.02). These results suggest that APCR may be an important mechanism of second-trimester pregnancy loss, possibly related to the increase in intravascular coagulation that occurs during pregnancy.lld:pubmed
pubmed-article:8603022pubmed:languageenglld:pubmed
pubmed-article:8603022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603022pubmed:citationSubsetIMlld:pubmed
pubmed-article:8603022pubmed:statusMEDLINElld:pubmed
pubmed-article:8603022pubmed:monthFeblld:pubmed
pubmed-article:8603022pubmed:issn0007-1048lld:pubmed
pubmed-article:8603022pubmed:authorpubmed-author:CohenHHlld:pubmed
pubmed-article:8603022pubmed:authorpubmed-author:ReganLLlld:pubmed
pubmed-article:8603022pubmed:authorpubmed-author:RajSSlld:pubmed
pubmed-article:8603022pubmed:authorpubmed-author:DaveMMlld:pubmed
pubmed-article:8603022pubmed:authorpubmed-author:HadleyEElld:pubmed
pubmed-article:8603022pubmed:issnTypePrintlld:pubmed
pubmed-article:8603022pubmed:volume92lld:pubmed
pubmed-article:8603022pubmed:ownerNLMlld:pubmed
pubmed-article:8603022pubmed:authorsCompleteYlld:pubmed
pubmed-article:8603022pubmed:pagination489-90lld:pubmed
pubmed-article:8603022pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:meshHeadingpubmed-meshheading:8603022-...lld:pubmed
pubmed-article:8603022pubmed:year1996lld:pubmed
pubmed-article:8603022pubmed:articleTitleSecond-trimester pregnancy loss is associated with activated C resistance.lld:pubmed
pubmed-article:8603022pubmed:affiliationDepartment of Obstetrics and Gynaecology, St Mary's Hospital, London.lld:pubmed
pubmed-article:8603022pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8603022pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8603022lld:pubmed